Distribution and composition of glycosaminoglycans in the left human coronary arterial branches under myocardial bridge

Atherosclerosis

Volumn 143, Issue 2, 1999, Pages 363-368

  Shinjo, Samuel K ^a   Prates, Nadir E V B ^b   Oba, Sueli M ^a   Sampaio, Lúcia O ^a   Nader, Helena B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chondroitin sulfate; Glycosaminoglycans; Heparan sulfate; Human coronary artery; Myocardial bridge

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; HEPARAN SULFATE;

ARTICLE; FUNCTIONAL ANATOMY; HEART VENTRICLE WALL; HUMAN; HUMAN TISSUE; LEFT CORONARY ARTERY; MEMBRANE FORMATION; PRIORITY JOURNAL;

EID: 0032894454     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00323-2     Document Type: Article

References (26)

1. Crainicianu A. Anatomische studien you ber bie coronararterien und exterinentelle untersuchungen uber ihre Durchgangigkeit. Virchows Arch Path Anat. 237:1922;1-8.
2. Polácek P. Relation of myocardial bridges and loops on the coronary arteries to coronary occlusions. Am Heart J. 61:1961;44-52.
3. Bezerra A.J.C., Didio L.J.A., Prates J.C. Pontes de Miocárdio. Ann Anat Nor. 5:1987;59-66.
4. Ying HL, Ying LC, Anraku AP, Prates, NEVB. Myocardium bridges in fetuses, new borns and children: morphological aspects - the São Paulo study. In: Proceedings of the XIII World Congress of Cardiology. Bologna: Monduzzi, 1998.
5. Geiringer E. The mural coronary. Am Heart J. 41:1951;359-368.
6. Lee S.S., Wu T.L. The role of the mural coronary artery in prevention of coronary atherosclerosis. Arch Pathol. 93:1972;32-35.
7. Portasmann W., Iwing J. Die intramurale koronarie im angiogramm. Fortschr Rontgenstr. 92:1960;129-132.
8. Ylä-Herttuala S., Nikkari T., Hirvonen J., Laaksonen M.M., Pesonen E., Raekallio J., Akerblom H.K. Biochemical composition of coronary arteries in Finnish children. Atherosclerosis. 6:1986;230-236.
9. Murata K., Yokoyama Y. Acidic glycosaminoglycans in human coronary arteries, with special reference to the presence of heparin or related glycosaminoglycan. Experimentia. 37:1981;1139-1141.
10. Murata K., Yokoyama Y. Acidic glycosaminoglycan, lipid and water contents in human coronary arterial branches. Atherosclerosis. 45:1982;53-65.
11. Stevens R.L., Colombo M., Gonzales J.J., Hollander W., Schmid K. The glycosaminoglycans of the human artery and their changes in atherosclerosis. J Clin Invest. 58:1976;470-481.
12. Tammi M., Seppälä P.O., Lehtonen A., Möttönen M. Connective tissue components in normal and atherosclerotic human coronary arteries. Atherosclerosis. 29:1978;191-194.
13. Ylä-Herttuala S., Sumuvuori H., Karkola K., Möttönen M., Nikkari T. Glycosaminoglycans in normal and atherosclerotic human coronary arteries. Lab Invest. 54:1986;402-407.
14. Dietrich C.P., Nader H.B. Fractionation and properties of four heparitin sulfates from beef lung tissues. Isolation and characterization of a homogeneous species of heparitin sulfate. Biochim Biophys Acta. 345:1974;34-45.
15. Nader H.B., Porcionatto M.A., Tersariol I.L.S., Pinhal M.A.S., Oliveira F.W., Moraes C.T., Dietrich C.P. Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. J Biol Chem. 265:1990;16807-16813.
16. Nader H.B., Ferreira T.M.P.C., Paiva J.F., Medeiros M.G.L., Jeronimo S.M.B., Paiva V.M.P.P., Dietrich C.P. Isolation and structural studies of heparan sulfates and chondroitin sulfates from three species of molluscs. J Biol Chem. 259:1984;1431-1435.
17. Dietrich C.P., Dietrich S.M. Electrophoretic behaviour of acidic mucopolysaccharides in diamine buffers. Anal Biochem. 70:1976;645-647.
18. Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem. 243:1968;1523-1535.
19. Dietrich C.P. A model for cell-cell recognition and control of cell growth mediated by sulfated glycosaminoglycans. Braz J Med Biol Res. 17:1984;5-15.
20. Kjellén L., Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem. 60:1991;443-475.
21. Radhakrishnamurthy B., Ruiz H.A., Dalferes E.R. Jr, Srinivasan S.R., Foster T.A., Berenson G.S. Studies of arterial wall glycosaminoglycans and collagen during experimental regression of atherosclerotic lesions in cynomolgus monkeys. Lab Invest. 47:1982;153-159.
22. Gutierrez P.S., Almeida I.C., Nader H.B., Higushi M.L., Stolf N., Dietrich C.P. Decrease in sulfated glycosaminoglycans in aortic dissection, possible role in the pathogenesis. Cardiovasc Res. 25:1991;742-748.
23. Radhakrishnamurthy B., Tracy R.E., Dalferes E.R. Jr, Berenson G.S. Proteoglycans in human coronary arteriosclerotic lesions. Exp Mol Pathol. 65:1998;1-8.
24. Buonassisi V., Colburn P. Antibodies to the heparan sulfate proteoglycans synthesized by endothelial cell cultures. Biochim Biophys Acta. 760:1983;1-12.
25. Nader H.B., Dietrich C.P., Buonassisi V., Colburn P. Heparin sequences in heparan sulfate chains of an endothelial cell proteoglycan. Proc Natl Acad Sci USA. 84:1987;3565-3572.
26. Marcum J.A., Atha D.H., Fritze L.M., Nawroth P., Stern D., Rosenberg R.D. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J Biol Chem. 261:1986;7507-7517.